Loading clinical trials...
Loading clinical trials...
Acceptance and Commitment Therapy for Problematic Chemsex: a Pilot Study
Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of problematic chemsex. As a pilot study, the intervention will be tested in a small group.
After being informed about the study, all patients giving written informed consent will be assessed to determine eligibility for study entry. Patients who meet eligibility requirements will receive psychological intervention consisting in an 8-session individual on line-delivered ACT-based treatment. The participants will be assessed through self-report instruments before and after treatment and at 3 months follow-up. The pilot study will not include a control group.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Universidad Europea de Madrid
Villaviciosa de Odón, Madrid, Spain
Start Date
March 1, 2024
Primary Completion Date
September 30, 2024
Completion Date
December 31, 2024
Last Updated
April 23, 2025
5
ACTUAL participants
Acceptance and Commitment Therapy (ACT)
BEHAVIORAL
Lead Sponsor
Universidad Europea de Madrid
Collaborators
NCT06406296
NCT07102303
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions